917 related articles for article (PubMed ID: 25288733)
21. Inhibition of Coronavirus Entry
Outlaw VK; Bovier FT; Mears MC; Cajimat MN; Zhu Y; Lin MJ; Addetia A; Lieberman NAP; Peddu V; Xie X; Shi PY; Greninger AL; Gellman SH; Bente DA; Moscona A; Porotto M
mBio; 2020 Oct; 11(5):. PubMed ID: 33082259
[TBL] [Abstract][Full Text] [Related]
22. Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease.
Stevaert A; Van Berwaer R; Mestdagh C; Vandeput J; Vanstreels E; Raeymaekers V; Laporte M; Naesens L
mBio; 2022 Aug; 13(4):e0137622. PubMed ID: 35913162
[TBL] [Abstract][Full Text] [Related]
23. Proteolytic activation of the spike protein at a novel RRRR/S motif is implicated in furin-dependent entry, syncytium formation, and infectivity of coronavirus infectious bronchitis virus in cultured cells.
Yamada Y; Liu DX
J Virol; 2009 Sep; 83(17):8744-58. PubMed ID: 19553314
[TBL] [Abstract][Full Text] [Related]
24. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.
Bestle D; Heindl MR; Limburg H; Van Lam van T; Pilgram O; Moulton H; Stein DA; Hardes K; Eickmann M; Dolnik O; Rohde C; Klenk HD; Garten W; Steinmetzer T; Böttcher-Friebertshäuser E
Life Sci Alliance; 2020 Sep; 3(9):. PubMed ID: 32703818
[TBL] [Abstract][Full Text] [Related]
25. Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization.
Kleine-Weber H; Elzayat MT; Wang L; Graham BS; Müller MA; Drosten C; Pöhlmann S; Hoffmann M
J Virol; 2019 Jan; 93(2):. PubMed ID: 30404801
[TBL] [Abstract][Full Text] [Related]
26. Proteolytic activation of SARS-CoV-2 spike protein.
Takeda M
Microbiol Immunol; 2022 Jan; 66(1):15-23. PubMed ID: 34561887
[TBL] [Abstract][Full Text] [Related]
27. Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection.
Menachery VD; Dinnon KH; Yount BL; McAnarney ET; Gralinski LE; Hale A; Graham RL; Scobey T; Anthony SJ; Wang L; Graham B; Randell SH; Lipkin WI; Baric RS
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801868
[TBL] [Abstract][Full Text] [Related]
28. Vero cell-adapted SARS-CoV-2 strain shows increased viral growth through furin-mediated efficient spike cleavage.
Minami S; Kotaki T; Sakai Y; Okamura S; Torii S; Ono C; Motooka D; Hamajima R; Nouda R; Nurdin JA; Yamasaki M; Kanai Y; Ebina H; Maeda Y; Okamoto T; Tachibana T; Matsuura Y; Kobayashi T
Microbiol Spectr; 2024 Apr; 12(4):e0285923. PubMed ID: 38415690
[TBL] [Abstract][Full Text] [Related]
29. Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition.
Navaratnarajah CK; Pease DR; Halfmann PJ; Taye B; Barkhymer A; Howell KG; Charlesworth JE; Christensen TA; Kawaoka Y; Cattaneo R; Schneider JW;
J Virol; 2021 Nov; 95(24):e0136821. PubMed ID: 34613786
[TBL] [Abstract][Full Text] [Related]
30. Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 Is an Important Surface Attachment Factor That Facilitates Entry of Middle East Respiratory Syndrome Coronavirus.
Chan CM; Chu H; Wang Y; Wong BH; Zhao X; Zhou J; Yang D; Leung SP; Chan JF; Yeung ML; Yan J; Lu G; Gao GF; Yuen KY
J Virol; 2016 Oct; 90(20):9114-27. PubMed ID: 27489282
[TBL] [Abstract][Full Text] [Related]
31. Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis.
Millet JK; Whittaker GR
Virus Res; 2015 Apr; 202():120-34. PubMed ID: 25445340
[TBL] [Abstract][Full Text] [Related]
32. Spread of Mutant Middle East Respiratory Syndrome Coronavirus with Reduced Affinity to Human CD26 during the South Korean Outbreak.
Kim Y; Cheon S; Min CK; Sohn KM; Kang YJ; Cha YJ; Kang JI; Han SK; Ha NY; Kim G; Aigerim A; Shin HM; Choi MS; Kim S; Cho HS; Kim YS; Cho NH
mBio; 2016 Mar; 7(2):e00019. PubMed ID: 26933050
[TBL] [Abstract][Full Text] [Related]
33. Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner.
Burkard C; Verheije MH; Wicht O; van Kasteren SI; van Kuppeveld FJ; Haagmans BL; Pelkmans L; Rottier PJ; Bosch BJ; de Haan CA
PLoS Pathog; 2014 Nov; 10(11):e1004502. PubMed ID: 25375324
[TBL] [Abstract][Full Text] [Related]
34. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells.
Hoffmann M; Kleine-Weber H; Pöhlmann S
Mol Cell; 2020 May; 78(4):779-784.e5. PubMed ID: 32362314
[TBL] [Abstract][Full Text] [Related]
35. Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein.
Xia S; Liu Q; Wang Q; Sun Z; Su S; Du L; Ying T; Lu L; Jiang S
Virus Res; 2014 Dec; 194():200-10. PubMed ID: 25451066
[TBL] [Abstract][Full Text] [Related]
36. Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay.
Yamamoto M; Matsuyama S; Li X; Takeda M; Kawaguchi Y; Inoue JI; Matsuda Z
Antimicrob Agents Chemother; 2016 Nov; 60(11):6532-6539. PubMed ID: 27550352
[TBL] [Abstract][Full Text] [Related]
37. Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein.
Li W; Hulswit RJG; Widjaja I; Raj VS; McBride R; Peng W; Widagdo W; Tortorici MA; van Dieren B; Lang Y; van Lent JWM; Paulson JC; de Haan CAM; de Groot RJ; van Kuppeveld FJM; Haagmans BL; Bosch BJ
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8508-E8517. PubMed ID: 28923942
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of proprotein convertases abrogates processing of the middle eastern respiratory syndrome coronavirus spike protein in infected cells but does not reduce viral infectivity.
Gierer S; Müller MA; Heurich A; Ritz D; Springstein BL; Karsten CB; Schendzielorz A; Gnirß K; Drosten C; Pöhlmann S
J Infect Dis; 2015 Mar; 211(6):889-97. PubMed ID: 25057042
[TBL] [Abstract][Full Text] [Related]
39. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
[TBL] [Abstract][Full Text] [Related]
40. Antiviral activity against Middle East Respiratory Syndrome coronavirus by Montelukast, an anti-asthma drug.
Gan HJ; Harikishore A; Lee J; Jeon S; Rajan S; Chen MW; Neo JL; Kim S; Yoon HS
Antiviral Res; 2021 Jan; 185():104996. PubMed ID: 33309540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
